title: Haemodialysis versus CAPD: equal predisposition to amyloidosis?
authors.forename: F W
authors.initials: FW
authors.lastname: Ballardie
authors.forename: D N
authors.initials: DN
authors.lastname: Kerr
authors.forename: G
authors.initials: G
authors.lastname: Tennent
authors.forename: M B
authors.initials: MB
authors.lastname: Pepys
mesh_terms: D000682:Amyloid / Q000097:blood; D000686:Amyloidosis / Q000209:etiology*; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D000682:Amyloid; D001613:beta 2-Microglobulin